APA (7th ed.) Citation

J, Z., J, P., G, H., Y, M., F, L., H, X., & H, L. (2026). PIK3CA mutation detection by circulating tumor cell sequencing guides the effective PI3K inhibitor treatment of a patient with hormone receptor-positive breast cancer transformed into triple-negative breast cancer: A case report. Medicine, 105(20), e48622. https://doi.org/10.1097/MD.0000000000048622

Chicago Style (17th ed.) Citation

J, Zhang, Pei J, Hao G, Meng Y, Li F, Xu H, and Liu H. "PIK3CA Mutation Detection by Circulating Tumor Cell Sequencing Guides the Effective PI3K Inhibitor Treatment of a Patient with Hormone Receptor-positive Breast Cancer Transformed into Triple-negative Breast Cancer: A Case Report." Medicine 105, no. 20 (2026): e48622. https://doi.org/10.1097/MD.0000000000048622.

MLA (9th ed.) Citation

J, Zhang, et al. "PIK3CA Mutation Detection by Circulating Tumor Cell Sequencing Guides the Effective PI3K Inhibitor Treatment of a Patient with Hormone Receptor-positive Breast Cancer Transformed into Triple-negative Breast Cancer: A Case Report." Medicine, vol. 105, no. 20, 2026, p. e48622, https://doi.org/10.1097/MD.0000000000048622.